Currently, there is no single test for multiple sclerosis (MS). Diagnosis is confirmed through
clinical evaluation, abnormalities revealed by magnetic resonance imaging (MRI), and …

Multiple sclerosis (MS) is associated with chronic degeneration of the central nervous
system and may cause permanent neurological problems and considerable disability. While …

Multiple sclerosis is a disabling inflammatory and neurodegenerative disorder that
predominantly affects young adults. There is a great need for biomarkers, which could …

Multiple sclerosis (MS) is a complex and heterogeneous disease in many different aspects,
for example, in its clinical manifestations, disease course, neuroradiological findings …

Multiple sclerosis (MS) is an immune mediated chronic inflammatory disease of the central
nervous system usually initiated during young adulthood, affecting approximately 2.5 million …

Multiple sclerosis, which is the most common cause of chronic neurological disability in
young adults, is an inflammatory, demyelinating, and neurodegenerative disease of the …

To identify markers in the CSF of multiple sclerosis (MS) subtypes, we used a two-step
proteomic approach:(i) Discovery proteomics compared 169 pooled CSF from MS subtypes …

Multiple sclerosis is an inflammatory‐mediated demyelinating disorder most prevalent in
young C aucasian adults. The various clinical manifestations of the disease present several …

Background Multiple sclerosis is an inflammatory and degenerative disease of the central
nervous system (CNS) characterized by demyelination and concomitant axonal loss. The …

Multiple sclerosis (MS) is a neuroinflammatory disorder characterized by autoimmune-
mediated inflammatory lesions in CNS leading to myelin damage and axonal loss. MS is a …